Lissencephaly therapeutic agent
AssigneeOsaka City University
InventorShinji Hirotsune
Life of this patent
Estimating the term…
Loading patent…
AssigneeOsaka City University
InventorShinji Hirotsune
Estimating the term…
An object of the present invention is to provide a medicament and method for treating lissencephaly patients. The present invention provides a lissencephaly therapeutic or preventive agent comprising a compound represented by the general formula (I): wherein R1 is lower alkyl substituted with lower alkoxy, lower alkyl substituted with a heterocyclic group, a heterocyclic group, or a group represented by the formula (IIa): wherein R4 is lower alkyl, R3 is lower alkylene, and m is an integer of 1 to 6; R2 is lower alkyl optionally substituted with phenyl; and R3 is lower alkyl optionally substituted with halogen, lower alkoxy, or phenyl; condensed polycyclic hydrocarbon; or hydrogen.
A method for treating lissencephaly comprising administering to a lissencephaly patient or a pregnant woman who is carrying a lissencephaly fetus, a compound represented by the general formula (I):
Dependencies are inferred from the claim text.